Exacerbated autoimmunity associated with a T helper-1 cytokine profile shift in H-2E-transgenic mice
- 1 November 1995
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 25 (11), 3134-3141
- https://doi.org/10.1002/eji.1830251122
Abstract
Major histocompatibility complex (MHC) class II genes are the strongest susceptibility markers for many human autoimmune diseases. A perplexing aspect of this is that HLA alleles can confer either susceptibility or dominant protection. In nonobese diabetic (NOD) mice, the strongest known diabetes susceptibility locus is within the MHC and is presumed to be the H-2Ag7 product. When NOD mice carry a transgenic Eαd molecule allowing expression of an H-2E heterodimer, diabetes is prevented. We investigated whether, as in human auto-immunity, a single class II heterodimer might protect from some autoimmune diseases while predisposing to others. NOD mice are susceptible to experimental autoimmune encephalomyelitis (EAE) induced by the proteolipoprotein (PLP) epitope 56–70. Susceptibility to EAE was analyzed in NOD mice which either have or lack transgenic H-2E expression. We found that H-2E expression in NOD mice has converse effects on diabetes and EAE: while diabetes is prevented, EAE is greatly exacerbated and leads to demyelination. Although PLP 56–70 could be presented both in the context of H-2A and H-2E, increased disease severity in H-2E transgenic mice could not be attributed either to an enhanced T cell proliferative response to PLP or to differences in determinant spread. However, cytokine analysis of the response revealed important differences between NOD mice and their H-2E transgenic counterparts: H-2E expression was associated with reduced interleukin-4 secretion and enhanced interferon-γ (IFN-γ) secretion by lymph node cells, while the response of central nervous system infiltrating T cells displayed a markedly enhanced IFN-γ response. Thus, whether a particular class II molecule confers resistance or susceptibility to an autoimmune disease may depend on differential cytokine profiles elicited by particular class II/autoantigen complexes.Keywords
This publication has 23 references indexed in Scilit:
- Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis.The Journal of Experimental Medicine, 1994
- The major histocompatibility complex influences myelin basic protein 63‐88‐induced T cell cytokine profile and experimental autoimmune encephalomyelitisEuropean Journal of Immunology, 1993
- Prevention of systemic lupus erythematosus in autoimmune BXSB mice by a transgene encoding I-E alpha chain.The Journal of Experimental Medicine, 1993
- The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetesEuropean Journal of Immunology, 1993
- I-E+ nonobese diabetic mice develop insulitis and diabetes.The Journal of Experimental Medicine, 1993
- Direct demonstration of the infiltration of murine central nervous system by Pgp-1/CD44high CD45RBlow CD4+ T cells that induce experimental allergic encephalomyelitisJournal of Neuroimmunology, 1992
- HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosisHuman Immunology, 1991
- Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chainNature, 1990
- Multiple discrete encephalitogenic epitopes of the autoantigen myelin basic protein include a determinant for I-E class II-restricted T cells.The Journal of Experimental Medicine, 1988
- Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse.The Journal of Experimental Medicine, 1987